Day: October 27, 2025

PROVIDENCE, R.I., Oct. 27, 2025 (GLOBE NEWSWIRE) — via IBN — (NASDAQ: BLNE) — Beeline Holdings, Inc. (“Beeline”), the digital mortgage lender built for next-generation homeowners, today announced the successful completion by its subsidiary, Beeline Loans, Inc. of its first round of blockchain-recorded BeelineEquity transactions, marking a major industry milestone as the first U.S. platform to tokenize residential home equity at scale. In its initial rollout, BeelineEquity closed five blockchain-tracked equity transactions, with five more scheduled this month and an additional 25 pre-selected to close before year-end. The company’s rapid adoption signals strong homeowner demand for an alternative to traditional home equity loans and refinances. BeelineEquity allows homeowners to unlock liquidity from their home equity...

MISSISSAUGA, Ontario, Oct. 27, 2025 (GLOBE NEWSWIRE) — Bird Construction Inc. (TSX: BDT) is pleased to announce that it has entered into a Development Phase Agreement (DPA) with Infrastructure Ontario (IO) and William Osler Health System (Osler) for the Peel Memorial Hospital Phase 2 Redevelopment project. This announcement follows Bird’s selection as the Preferred Proponent, announced September 29, 2025, and marks the commencement of the Development Phase. As Development Partner, Bird will work in close collaboration with Osler and IO to advance the project’s design, schedule, pricing, and risk parameters under a progressive design-build model. Upon successful completion of the Development Phase, Bird expects to enter into a target price Project Agreement to deliver the project. “The DPA for the Peel Memorial Hospital Phase 2...

All amounts are in United States dollars, unless otherwise stated. TORONTO, Oct. 27, 2025 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (together with its direct and indirect subsidiaries, “Alamos” or the “Company”) today announced that its wholly owned Netherlands subsidiaries, Alamos Gold Holdings Coöperatief U.A. and Alamos Gold Holdings B.V. (the “Netherlands Subsidiaries”), have completed the sale of Doğu Biga Madencilik Sanayi ve Tic. A.Ş., their wholly owned Turkish subsidiary, which owns the Kirazlı, Ağı Dağı and Çamyurt projects located in northwestern Türkiye, to Tümad Madencilik Sanayi ve Ticaret A.Ş. (“Tümad”), a mining company operating in the Republic of Türkiye, for total cash consideration of $470 million (the “Transaction”). Upon closing, Alamos received $160 million in cash. On the one-year and two-year...

DENVER, Oct. 27, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that the construction of VENU’s (NYSE American: VENU) $350 million Sunset Amphitheater in McKinney, Texas, is progressing on schedule, marking a major milestone in the company’s mission to redefine the live entertainment landscape through real estate–backed, community-integrated entertainment campuses.The state-of-the-art, 20,000-seat premium amphitheater is projected to begin its inaugural concert season in 2026, which could grow to more than 80 shows annually, in its first full year, featuring premier global talent. Strategically located at the intersection of US 75 and the Sam Rayburn Tollway, the Sunset Amphitheater sits within a 30-minute drive of nearly...

Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026 PHOENIX, Oct. 27, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company pioneering regenerative immunotherapy, today issued a Letter to Shareholders from Timothy Warbington, Co-Founder and Chief Executive Officer. Dear Fellow Shareholders: 2025 has been a landmark year for Creative Medical. With the support of the most comprehensive clinical, intellectual, and technological foundation in our Company’s history, we have evolved from proof-of-concept to clinical trials in support of our mission to develop breakthrough regenerative stem cell therapies across multiple indications. At the same time,...

Washington, DC, Oct. 27, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital (NASDAQ: ATON) is proud to announce that Brittany Kaiser, CEO, will be a featured speaker at the Future of Money, Governance, and the Law (FoMGL) summit, taking place on Capitol Hill on October 30, 2025. Hosted by the Government Blockchain Association (GBA) and The Edge Of Company, Inc., this landmark event brings together global leaders, policymakers, and innovators shaping the future of digital assets, governance, and technology regulation. Brittany Kaiser is internationally recognized for her leadership in digital rights, data sovereignty, and ethical innovation in Web3. At AlphaTON Capital, she helps drive investments in early-stage blockchain and AI ventures that prioritize transparency, user empowerment, and regulatory clarity values that reflect AlphaTON’s...

Veteran Engineer with 15 Years of Leadership at Maris-Tech to Guide the Next Phase of Innovation in Video and AI Edge Computing Rehovot, Israel, Oct. 27, 2025 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and artificial intelligence (“AI”) – based edge computing technology, today announced the appointment of Hananya Malka as the Company’s Chief Technology Officer (CTO), as successor to Magenya Roshanski, who is retiring from the Company after many years of dedicated service. Hananya Malka has been with Maris-Tech for the past 15 years, most recently serving as research and development manager. He led the development of advanced video processing systems deployed in defense, homeland security and space applications. Mr. Malka holds a B.Sc. from Ariel University...

BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has received a Paragraph IV Certification Notice Letter (PIV Notice) from Qilu Pharmaceutical (Hainan) Co., Ltd., a private Chinese company. Qilu has filed an Abbreviated New Drug Application, or ANDA, with the FDA for a product claiming to be a generic equivalent of EXPAREL. In the PIV Notice, Qilu alleges that the claims of 18 EXPAREL patents listed in the FDA’s Orange Book (U.S. Patent Nos.11,033,495, 11,179,336, 11,278,494, 11,304,904, 11,311,486, 11,357,727, 11,426,348, 11,452,691, 11,819,574, 11,819,575, 11,925,706, 12,144,890, 12,151,024, 12,156,940, 12,251,468, 12,296,047, 12,318,483, 12,370,142)...

MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 2025 UBS Global Healthcare Conference on Monday, November 10, 2025. Inspire is scheduled to present at 11:45 a.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com. About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative,...